This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan chromogenic IHC-P for DDC using renal proximal tubules as a positive control (HPA tissue IHC). Assess cytoplasmic staining while accounting for presumed off-target binding (HPA tissue IHC).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Cytoplasmic staining in several tissues (HPA tissue IHC) | |
| Staining pattern | Strong cytoplasmic staining in renal proximal tubules (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A01374-2) | |
| Positive control | Appendix+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
| Fixation | Keep fixation consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Presumed off-target staining was observed (HPA tissue IHC) | |
| Regulation | High expression in kidney (UniProt) | |
| Isoform / epitope | 4 isoforms; check epitope coverage (UniProt) |
The catalog antibody’s IHC-P protocol and one published DDC IHC protocol are presented here (datasheet: IHC-P; PMC10593861: DDC IHC).
| Sample | Paraffin-embedded human kidney tissue; fixative not specified (datasheet A01374-2) |
| Fixation | Image fixative and duration unreported (datasheet A01374-2); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A01374-2); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A01374-2) |
| Primary antibody | Rabbit anti-DDC, 2-5 μg/ml (datasheet A01374-2) |
| Primary incubation | Overnight at 4 °C (datasheet A01374-2) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A01374-2) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | DDC-positive staining in endocrine cells of appendix (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in several tissues, most abundant in renal tubules. No signal in the no-primary control. |
DDC staining should be predominantly cytoplasmic, strongest in kidney proximal tubule cell bodies and visible in intestinal endocrine cells (HPA tissue IHC: high). HPA rates the tissue pattern Enhanced while noting presumed off-target binding, so assess both cell identity and compartment (HPA tissue IHC: Enhanced). UniProt lists no transmembrane segment and provides no subcellular annotation (UniProt P20711 topology and subcellular record).
| Strong cytoplasmic staining in kidney proximal tubule cell bodies. | This is the clearest tissue benchmark: HPA reports high proximal tubule staining and describes renal tubules as the most abundant site (HPA tissue IHC). Score the tubule cells rather than assigning every stained structure in the section to DDC. |
| Cytoplasmic staining in scattered endocrine cells of appendix or intestinal mucosa. | HPA reports high staining in endocrine cells of appendix, colon, duodenum, rectum and small intestine (HPA tissue IHC). A selective cell pattern is more consistent with that evidence than uniform staining of adjacent epithelium. |
| Predominantly nuclear, sharply membranous or extracellular signal in a kidney section. | This differs from HPA's cytoplasmic renal pattern (HPA tissue IHC). UniProt reports no transmembrane segment or signal peptide (UniProt P20711 topology and processing). Check morphology and controls before interpreting it as DDC. |
| Broad staining of cell types reported as undetected, such as adipocytes or marrow hematopoietic cells. | HPA reports DDC as not detected in those specified cells and notes presumed off-target binding in its tissue assessment (HPA tissue IHC). Treat broad staining there as a specificity concern; a single negative cell type cannot prove cross-reactivity. |
| Little or no staining in kidney proximal tubule cell bodies. | This conflicts with HPA's high renal benchmark (HPA tissue IHC). First check that proximal tubules are present and identifiable, then review the antibody and IHC detection controls (general IHC practice). |
| Choice of tissue and cell type | Kidney proximal tubules offer a high-signal reference; intestinal endocrine cells are another high-staining population, while adipocytes and marrow hematopoietic cells are reported undetected (HPA tissue IHC). Compare the named cells, not whole-section colour. |
| Antibody validation and interpretation | HPA lists HPA017742 as IHC Enhanced and describes the tissue profile as Enhanced, with medium agreement between staining and RNA and presumed off-target binding disregarded (HPA antibodies; HPA tissue IHC). Validation supports use of the pattern but does not identify every stained cell. |
| Topology and processing | UniProt lists one 1–480 chain, no signal peptide, no propeptide and no transmembrane segment (UniProt P20711 topology and processing). These features give no basis to expect a membrane-rim or secreted-protein pattern; HPA tissue IHC supplies the observed cytoplasmic benchmark. |
| Isoforms and antibody epitope | UniProt lists four DDC isoforms, but the supplied records do not map the antibody epitope or establish isoform-specific staining (UniProt P20711 isoforms; HPA antibodies). Do not infer which isoform accounts for a stronger or weaker cell signal. |
| IF/ICC: should its pattern set the IHC-P scoring rule? | No. HPA ICC-IF reports approved actin-filament localisation plus a primary-cilium location, whereas HPA tissue IHC describes cytoplasmic staining (HPA subcellular; HPA tissue IHC). Use each assay's own observed pattern; filament or cilium detail is not an IHC-P requirement. |
| Chromogenic detection chemistry | Endogenous peroxidase or pigment can complicate a brown chromogenic readout; a no-primary control and appropriate blocking help distinguish detection background from antibody-dependent signal (general IHC practice). This is a general workflow consideration, not a reported DDC-specific effect. |
| Situation | Likely cause | Next action |
|---|---|---|
| Kidney positive control lacks proximal tubule signal. | The target cell population may be absent from the field, or staining and detection conditions may have failed (HPA tissue IHC: high in proximal tubules; general IHC practice). | Confirm proximal tubule morphology, then check the catalog antibody's IHC-P instructions, retrieval conditions and detection controls (general IHC practice). The supplied evidence does not establish DDC-specific retrieval sensitivity. |
| Diffuse brown haze obscures cell boundaries. | Background may arise from detection chemistry, residual endogenous peroxidase or nonspecific antibody binding (general IHC practice); HPA also notes presumed off-target binding in its tissue assessment (HPA tissue IHC). | Inspect a no-primary control, review peroxidase blocking and washing, and compare signal with clearly defined renal tubule cells (general IHC practice; HPA tissue IHC: high in proximal tubules). |
| Most intestinal epithelial cells stain uniformly. | That distribution exceeds the endocrine-cell pattern reported for intestinal sites and may indicate nonspecific staining (HPA tissue IHC: high in endocrine cells; general IHC practice). | Identify endocrine cells on the section and compare antibody staining with a no-primary control; reassess the result if colour follows broad epithelium instead (HPA tissue IHC; general IHC practice). |
| Signal appears mainly nuclear or as a membrane rim. | The compartment conflicts with HPA's cytoplasmic tissue profile; UniProt supplies no transmembrane segment (HPA tissue IHC; UniProt P20711 topology). | Check focus, counterstain and control sections, then score DDC only where staining matches the expected cell and cytoplasmic pattern (general IHC practice; HPA tissue IHC). |
| Adipocytes or marrow hematopoietic cells show strong staining. | HPA reports these particular cells as not detected and acknowledges presumed off-target binding (HPA tissue IHC). The staining alone cannot identify whether antibody binding or detection chemistry caused it. | Compare a no-primary control and the kidney proximal tubule benchmark; treat persistent antibody-dependent staining in those cells as a specificity concern (general IHC practice; HPA tissue IHC). |
| An IF/ICC image looks filamentous while the IHC section looks cytoplasmic. | The two HPA records report different assay observations: actin filaments and primary cilium in ICC-IF, cytoplasmic tissue staining in IHC (HPA subcellular; HPA tissue IHC). | Interpret the paraffin section against the HPA tissue cell pattern and the IF/ICC image against its own localisation record; do not require visible filaments in chromogenic IHC-P (HPA tissue IHC; HPA subcellular). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — Medium consistency between antibody staining and RNA expression data. Presumed off target binding observed and disregarded.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | Endocrine cells | High | Protein (IHC) | HPA → |
| Cerebellum | Molecular layer - neuropil | High | Protein (IHC) | HPA → |
| Colon | Endocrine cells | High | Protein (IHC) | HPA → |
| Duodenum | Endocrine cells | High | Protein (IHC) | HPA → |
| Kidney | Proximal tubules (cell body) | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Caudate | Glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebral cortex | Endothelial cells | Not detected | Protein (IHC) | HPA → |
| Cervix | Glandular cells | Not detected | Protein (IHC) | HPA → |
Troubleshoot DDC staining in paraffin sections by checking retrieval, cell type, compartment, controls, and scoring against the documented kidney example.
Two anti-DDC antibodies have human IHC images: kidney for A01374-2 and lung for A01374 (catalog IHC captions). A01374 also has a human lung IF image (catalog IF caption).
A01374-2 shows IHC staining in a paraffin-embedded human kidney section (A01374-2 IHC caption). A01374 shows IHC staining in human lung tissue and IF staining in human lung tissue (A01374 IHC and IF captions).
Which to pick: For paraffin-section IHC, choose A01374-2: its kidney image documents antigen retrieval and chromogenic detection, with a listed IHC concentration of 2–5 μg/ml (A01374-2 IHC caption; catalog dilution). For IF, choose A01374 based on its human lung IF image; ICC validation is unreported (A01374 IF caption; catalog applications). Both list human, mouse, and rat reactivity, but the supplied IHC and IF images show human tissue only; neither IHC caption reports the fixative (catalog reactivity; A01374-2 and A01374 IHC captions).